<DOC>
	<DOCNO>NCT01794637</DOCNO>
	<brief_summary>End - stage liver disease cause many problem patient include fatigue , weakness , jaundice , confusion , abdominal pain distension . Another important problem cardiovascular system ( heart blood vessel ) . There impairment heart function pump blood distal part body . Blood vessel also affect imbalance chemical agent detoxify diseased liver , result impairment oxygen carry capacity tissue oxygen exchange . Mechanism process still poorly understood . This study peripheral vascular dysfunction mean vascular occlusion test ( VOT ) . Blood pressure cuff inflate ( occlude proximal vessel induce distal part ischemia ) , deflate observe distal tissue oxygenation ( StO2 ) change probe ( Near-infrared spectroscopy : NIRS ) hand . From knowledge , study patient undergo liver transplantation . The study investigator would like observe change peripheral tissue oxygenation different time point liver transplantation . We hypothesize change microcirculatory function StO2 end-stage liver disease patient detect VOT NIRS .</brief_summary>
	<brief_title>Study Peripheral Tissue Oxygenation End-stage Liver Disease Patients During Liver Transplantation</brief_title>
	<detailed_description>End - stage liver disease patient schedule liver transplantation enrol . They receive normal standard care . The VOT assessment use non-invasive , integrate research device ( InspectraTM StO2 Vascular Occlusion test ( VOT ) Research Device Hutchinson Corp Minn , MN , USA ) 15 mm Inspectra thenar sensor probe . An integrated blood pressure cuff place right arm inflated pressure sufficient produce arterial inflow occlusion ( 50mmHg systolic pressure ) . The cuff remain inflated StO2 value 40 % achieve . During inflation deflation , various StO2 parameter measure record design time point . Specific VOT parameter interest : - Baseline StO2 ( reflective perfusion/metabolism ratio ) - Ischemia slope ( partly reflective basal O2 consumption ) - Ischemia area ( partly reflective basal O2 consumption ) - Time till 40 % ischemic threshold ( partly reflective basal O2 consumption ) - Recovery slope ( biphasic reflective shear stress endothelial vasoreactivity ) - Recovery area ( reflective endothelial vasoreactivity ) - Hyperemia area ( reflective endothelial vasoreactivity tissue metabolic rate ) To determine effect core versus peripheral temperature , conventional skin thermocouple place adhesive patch use secure NIRS optodes position thenar eminence Data collection 1 . Demographic data : ) age , b ) sex , c ) diagnosis , ) Model End-stage Liver Disease ( MELD ) score , Body Mass Index ( BMI ) 2 . Clinical parameter : investigator collect clinical data include VOT parameter ( ) , hemodynamics parameter , chemical parameter medication use specific time frame : - time frame 1. pre-operative ( base line data ) 2. pre-anhepatic phase ( 15 min . inferior vena cava ( IVC ) clamp ) 3. anhepatic phase ( 30 min . IVC clamp ) , 4. reperfusion phase ( 30 min . release IVC clamp ) , 5. immediately post operation ( skin closure ) - hemodynamics : SpO2 ( Pulse oxygen saturation ) , MAP ( mean arterial pressure ) , HR ( heart rate ) , CVP ( Central venous pressure ) , PAP ( Pulmonary artery pressure ) , CI ( Cardiac output index ) , PCWP ( Pulmonary artery wedge pressure ) , SVRI ( Systemic vascular resistance index ) , PVRI ( Pulmonary vascular resistance index ) , temperature - chemical : Hb , Platelets , INR ( international normalize ratio ) ( PT : Prothrombin time ) , PTT ( partial thromboplastin time ) , Lactate , base excess - Medications : Volatile agent , Vasopressors ( Concentration record time point ) Then compare dynamic change StO2 parameter different time point ( mention ) compare hemodynamics chemical parameter .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Adult patient suffer endstage liver disease schedule liver transplantation . Patients known peripheral vascular disease Patients receive Oxygen therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>End stage liver disease</keyword>
	<keyword>Peripheral microcirculatory dysfunction</keyword>
	<keyword>Liver transplantation</keyword>
	<keyword>Near infrared spectroscopy</keyword>
</DOC>